252 related articles for article (PubMed ID: 9526947)
1. Effect of glycoprotein IIb/IIIa antagonists on the HIT serum induced activation of platelets.
Jeske WP; Walenga JM; Szatkowski E; Ero M; Herbert JM; Haas S; Bakhos M
Thromb Res; 1997 Nov; 88(3):271-81. PubMed ID: 9526947
[TBL] [Abstract][Full Text] [Related]
2. In vitro efficacy of platelet glycoprotein IIb/IIIa antagonist in blocking platelet function in plasma of patients with heparin-induced thrombocytopenia.
Mak KH; Kottke-Marchant K; Brooks LM; Topol EJ
Thromb Haemost; 1998 Dec; 80(6):989-93. PubMed ID: 9869172
[TBL] [Abstract][Full Text] [Related]
3. Heparin-induced thrombocytopenia: the role of platelet activation and therapeutic implications.
Haas S; Walenga JM; Jeske WP; Fareed J
Semin Thromb Hemost; 1999; 25 Suppl 1():67-75. PubMed ID: 10357155
[TBL] [Abstract][Full Text] [Related]
4. Platelet GPIIb/IIIa antagonist, XV459, in heparin-induced thrombocytopenia.
Mousa SA; Ahmad S
Am J Hematol; 2007 Apr; 82(4):276-82. PubMed ID: 17039513
[TBL] [Abstract][Full Text] [Related]
5. The effect of a novel glycoprotein IIb/IIIa antagonist, SR 121566A, on platelet aggregation and activation in rhesus monkeys.
Orcullo Santillan MK; Herring J; Hoppensteadt DA; Jeske W; Herbert JM; Fareed J
Clin Appl Thromb Hemost; 2001 Jan; 7(1):10-5. PubMed ID: 11190897
[TBL] [Abstract][Full Text] [Related]
6. Effect of SR121566A, a potent GP IIb-IIIa antagonist, on the HIT serum/heparin-induced platelet mediated activation of human endothelial cells.
Herbert JM; Savi P; Jeske WP; Walenga JM
Thromb Haemost; 1998 Aug; 80(2):326-31. PubMed ID: 9716161
[TBL] [Abstract][Full Text] [Related]
7. Platelet activation as a potential mechanism of GP IIb/IIIa inhibitor-induced thrombocytopenia.
Peter K; Straub A; Kohler B; Volkmann M; Schwarz M; Kübler W; Bode C
Am J Cardiol; 1999 Sep; 84(5):519-24. PubMed ID: 10482148
[TBL] [Abstract][Full Text] [Related]
8. In vitro inhibition of heparin-induced platelet aggregation in plasma from patients with HIT by SR 121566, a newly developed Gp IIb/IIIa antagonist.
Hérault JP; Lalé A; Savi P; Pflieger AM; Herbert JM
Blood Coagul Fibrinolysis; 1997 Apr; 8(3):206-7. PubMed ID: 9167024
[No Abstract] [Full Text] [Related]
9. Pharmacologic platelet anesthesia by glycoprotein IIb/IIIa complex antagonist and argatroban during in vitro extracorporeal circulation.
Kanemitsu S; Nishikawa M; Onoda K; Shimono T; Shimpo H; Yazaki A; Tanaka K; Shiku H; Yada I
J Thorac Cardiovasc Surg; 2003 Aug; 126(2):428-35. PubMed ID: 12928640
[TBL] [Abstract][Full Text] [Related]
10. Development of a non-human primate sub-clinical model of heparin-induced thrombocytopenia: platelet responses to human anti-heparin-platelet factor 4 antibodies.
Untch B; Ahmad S; Messmore HL; Schultz CL; Ma Q; Hoppensteadt DA; Walenga JM; Fareed J
Thromb Res; 2002 Apr; 106(2):149-56. PubMed ID: 12182915
[TBL] [Abstract][Full Text] [Related]
11. Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptors.
Gawaz M; Ruf A; Pogatsa-Murray G; Dickfeld T; Rüdiger S; Taubitz W; Fischer J; Müller I; Meier D; Patscheke H; Schömig A
Thromb Haemost; 2000 Jun; 83(6):915-22. PubMed ID: 10896249
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of glycoprotein IIb/IIIa antagonists and aspirin on the release of soluble CD40 ligand during platelet stimulation.
Nannizzi-Alaimo L; Alves VL; Phillips DR
Circulation; 2003 Mar; 107(8):1123-8. PubMed ID: 12615789
[TBL] [Abstract][Full Text] [Related]
13. Paradoxical inhibition of fibrinogen binding and potentiation of alpha-granule release by specific types of inhibitors of glycoprotein IIb-IIIa.
Schneider DJ; Taatjes DJ; Sobel BE
Cardiovasc Res; 2000 Jan; 45(2):437-46. PubMed ID: 10728364
[TBL] [Abstract][Full Text] [Related]
14. In vitro measurement of platelet glycoprotein IIb/IIIa receptor blockade by abciximab: interindividual variation and increased platelet secretion.
Rossi F; Rossi E; Pareti FI; Colli S; Tremoli E; Gallo L
Haematologica; 2001 Feb; 86(2):192-8. PubMed ID: 11224490
[TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro efficacy of different platelet glycoprotein IIb/IIIa antagonists on platelet-mediated clot strength induced by tissue factor with use of thromboelastography: differentiation among glycoprotein IIb/IIIa antagonists.
Mousa SA; Khurana S; Forsythe MS
Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):1162-7. PubMed ID: 10764688
[TBL] [Abstract][Full Text] [Related]
16. Adenosine diphosphate (ADP) and ADP receptor play a major role in platelet activation/aggregation induced by sera from heparin-induced thrombocytopenia patients.
Polgár J; Eichler P; Greinacher A; Clemetson KJ
Blood; 1998 Jan; 91(2):549-54. PubMed ID: 9427708
[TBL] [Abstract][Full Text] [Related]
17. Studies on the binding of 3H-SR121566, an inhibitor of Gp IIb-IIIa activation.
Savi P; Zamboni G; Rescanières O; Herbert JM
Thromb Haemost; 2001 Apr; 85(4):702-9. PubMed ID: 11341508
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofiban.
Koster A; Kukucka M; Bach F; Meyer O; Fischer T; Mertzlufft F; Loebe M; Hetzer R; Kuppe H
Anesthesiology; 2001 Feb; 94(2):245-51. PubMed ID: 11176088
[TBL] [Abstract][Full Text] [Related]
19. Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement.
Gawaz M; Ruf A; Neumann FJ; Pogátsa-Murray G; Dickfeld T; Zohlnhöfer D; Schömig A
Thromb Haemost; 1998 Dec; 80(6):994-1001. PubMed ID: 9869173
[TBL] [Abstract][Full Text] [Related]
20. The GP IIb/IIIa inhibitor abciximab (ReoPro) decreases activation and interaction of platelets and leukocytes during in vitro cardiopulmonary bypass simulation.
Straub A; Wendel HP; Azevedo R; Ziemer G
Eur J Cardiothorac Surg; 2005 Apr; 27(4):617-21. PubMed ID: 15784360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
